Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001280044-26-000004

Director acquired 11,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GOWEN MAXINE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-05 Exercise or conversion : show line 1 in the form +11,580 33,334 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-06-04 Grant or award : show line 2 in the form Stock Option (Right to Buy) +42,350 42,350 D
2026-06-04 Grant or award : show line 3 in the form Restricted Stock Units +10,987 10,987 D
2026-06-05 Exercise or conversion : show line 4 in the form Restricted Stock Units −11,580 0 D
Loading xslF345X06/form4-06082026_040601.xml…